HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xia Zeng Selected Research

Acrosin

1/2021Combined treatment with epigenetic agents enhances anti-tumor activity of T cells by upregulating the ACRBP expression in hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xia Zeng Research Topics

Disease

7Neoplasms (Cancer)
01/2024 - 01/2020
5Testicular Neoplasms (Testicular Cancer)
12/2023 - 01/2020
2Chronic Disease (Chronic Diseases)
01/2024 - 01/2021
2Sepsis (Septicemia)
01/2024 - 01/2010
2Infections
01/2024 - 01/2023
2Inflammation (Inflammations)
10/2022 - 01/2021
2Diabetic Nephropathies (Diabetic Nephropathy)
01/2022 - 09/2021
2Obesity
01/2022 - 01/2018
2Glioma (Gliomas)
01/2022 - 01/2020
2Hepatocellular Carcinoma (Hepatoma)
01/2021 - 08/2020
1Cytokine Release Syndrome
01/2024
1Pancreatitis
01/2024
1Acute-On-Chronic Liver Failure
01/2024
1Hepatitis B
01/2024
1Atrophy
01/2024
1Chronic Obstructive Pulmonary Disease (COPD)
01/2024
1Sarcopenia
01/2024
1Orthomyxoviridae Infections
01/2024
1Pain (Aches)
10/2023
1Jaundice (Icterus)
02/2023
1Non-alcoholic Fatty Liver Disease
10/2022
1Diabetes Mellitus
10/2022
1Liver Cirrhosis (Hepatic Cirrhosis)
10/2022
1Glucose Metabolism Disorders
10/2022
1Fatty Liver
01/2022
1Ovarian Neoplasms (Ovarian Cancer)
12/2021
1Ovarian Epithelial Carcinoma
12/2021
1Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2021
1Mitochondrial Diseases (Mitochondrial Disease)
01/2021
1Alzheimer Disease (Alzheimer's Disease)
01/2021
1Cognitive Dysfunction
01/2021
1Fibrosis (Cirrhosis)
08/2020
1Abdominal Obesity
01/2018
1Critical Illness (Critically Ill)
01/2010

Drug/Important Bio-Agent (IBA)

5AntigensIBA
12/2023 - 01/2020
4Messenger RNA (mRNA)IBA
01/2024 - 01/2020
3Proteins (Proteins, Gene)FDA Link
12/2021 - 01/2020
2Peptides (Polypeptides)IBA
12/2023 - 01/2022
2Interleukin-18 (Interleukin 18)IBA
10/2022 - 01/2010
2theasinensin AIBA
01/2022 - 01/2021
2DecitabineFDA Link
01/2022 - 01/2021
2Valproic Acid (Depakote)FDA LinkGeneric
01/2022 - 01/2021
2trichostatin A (A 300)IBA
01/2022 - 01/2021
15-hydroxymethylcytosineIBA
01/2024
1GuanineIBA
01/2024
15-formylcytosineIBA
01/2024
15-carboxylcytosineIBA
01/2024
15-Methylcytosine (5 Methylcytosine)IBA
01/2024
1Triglycerides (Triacylglycerol)IBA
01/2024
1Antiviral Agents (Antivirals)IBA
01/2024
1LuciferasesIBA
01/2024
1MicroRNAs (MicroRNA)IBA
01/2024
1RNA (Ribonucleic Acid)IBA
01/2024
1SmokeIBA
01/2024
1Cancer VaccinesIBA
12/2023
1EpitopesIBA
12/2023
1HLA-A*02:01 antigenIBA
12/2023
1Opioid Analgesics (Opioids)IBA
10/2023
1Hematoxylin (Haematoxylon)IBA
01/2023
1Eosine Yellowish-(YS) (Eosin)IBA
01/2023
1A-factor (Streptomyces)IBA
10/2022
1LipidsIBA
10/2022
1Streptozocin (Streptozotocin)FDA Link
10/2022
1InflammasomesIBA
10/2022
1trilobatinIBA
10/2022
1HLA-A2 Antigen (HLA A2 Antigen)IBA
01/2022
1Serine (L-Serine)FDA Link
01/2022
1Phosphoglycerate Dehydrogenase (Dehydrogenase, Phosphoglycerate)IBA
01/2022
1Biomarkers (Surrogate Marker)IBA
12/2021
1IsoflavonesIBA
09/2021
1Amyloid beta-PeptidesIBA
01/2021
1Carrier Proteins (Binding Protein)IBA
01/2021
1AcrosinIBA
01/2021
1TaurineFDA Link
01/2021
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2020
1ORALIT (ORS)IBA
01/2018
1ImmunosorbentsIBA
01/2010
1EnzymesIBA
01/2010

Therapy/Procedure

6Immunotherapy
12/2023 - 01/2020
1Plasmapheresis
01/2024
1Artificial Liver (Bioartificial Liver)
01/2024
1Therapeutics
12/2023
1Dry Needling
10/2023
1Percutaneous Collagen Induction
10/2023
1Pain Management
10/2023
1Pancreaticoduodenectomy
02/2023
1Oral Administration
01/2022
1Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2021